Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil
Andrea Prontera,1 Stefano Baroni,2 Andrea Marudi,2 Franco Valzania,3 Alberto Feletti,1 Francesca Benuzzi,4 Elisabetta Bertellini,2 Giacomo Pavesi1 1Department of Neurosurgery, Nuovo Ospedale Civile SAgostino-Estense, 2Department of Anesthesiology, Nuovo Ospedale Civile SAgostino-Estense, 3Departmen...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/awake-craniotomy-anesthetic-management-using-dexmedetomidine-propofol--peer-reviewed-article-DDDT |
id |
doaj-562f0e1d5ee84ef5b21bace140fdd6fb |
---|---|
record_format |
Article |
spelling |
doaj-562f0e1d5ee84ef5b21bace140fdd6fb2020-11-24T23:24:04ZengDove Medical PressDrug Design, Development and Therapy1177-88812017-03-01Volume1159359831678Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanilProntera ABaroni SMarudi AValzania FFeletti ABenuzzi FBertellini EPavesi GAndrea Prontera,1 Stefano Baroni,2 Andrea Marudi,2 Franco Valzania,3 Alberto Feletti,1 Francesca Benuzzi,4 Elisabetta Bertellini,2 Giacomo Pavesi1 1Department of Neurosurgery, Nuovo Ospedale Civile SAgostino-Estense, 2Department of Anesthesiology, Nuovo Ospedale Civile SAgostino-Estense, 3Department of Neurology, Nuovo Ospedale Civile S Agostino-Estense, 4Department of Neuroscience, University of Modena and Reggio Emilia, Modena, Italy Introduction: Awake craniotomy allows continuous monitoring of patients’ neurological functions during open surgery. Anesthesiologists have to sedate patients in a way so that they are compliant throughout the whole surgical procedure, nevertheless maintaining adequate analgesia and anxiolysis. Currently, the use of α2-receptor agonist dexmedetomidine as the primary hypnotic–sedative medication is increasing.Methods: Nine patients undergoing awake craniotomy were treated with refined monitored anesthesia care (MAC) protocol consisting of a combination of local anesthesia without scalp block, low-dose infusion of dexmedetomidine, propofol, and remifentanil, without the need of airways management.Results: The anesthetic protocol applied in our study has the advantage of decreasing the dose of each drug and thus reducing the occurrence of side effects. All patients had smooth and rapid awakenings. The brain remained relaxed during the entire procedure.Conclusion: In our experience, this protocol is safe and effective during awake brain surgery. Nevertheless, prospective randomized trials are necessary to confirm the optimal anesthetic technique to be used. Keywords: dexmedetomidine, awake surgery, anesthesiahttps://www.dovepress.com/awake-craniotomy-anesthetic-management-using-dexmedetomidine-propofol--peer-reviewed-article-DDDTDexmedetomidineAwake surgeryAnesthesia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Prontera A Baroni S Marudi A Valzania F Feletti A Benuzzi F Bertellini E Pavesi G |
spellingShingle |
Prontera A Baroni S Marudi A Valzania F Feletti A Benuzzi F Bertellini E Pavesi G Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil Drug Design, Development and Therapy Dexmedetomidine Awake surgery Anesthesia |
author_facet |
Prontera A Baroni S Marudi A Valzania F Feletti A Benuzzi F Bertellini E Pavesi G |
author_sort |
Prontera A |
title |
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil |
title_short |
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil |
title_full |
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil |
title_fullStr |
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil |
title_full_unstemmed |
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil |
title_sort |
awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil |
publisher |
Dove Medical Press |
series |
Drug Design, Development and Therapy |
issn |
1177-8881 |
publishDate |
2017-03-01 |
description |
Andrea Prontera,1 Stefano Baroni,2 Andrea Marudi,2 Franco Valzania,3 Alberto Feletti,1 Francesca Benuzzi,4 Elisabetta Bertellini,2 Giacomo Pavesi1 1Department of Neurosurgery, Nuovo Ospedale Civile SAgostino-Estense, 2Department of Anesthesiology, Nuovo Ospedale Civile SAgostino-Estense, 3Department of Neurology, Nuovo Ospedale Civile S Agostino-Estense, 4Department of Neuroscience, University of Modena and Reggio Emilia, Modena, Italy Introduction: Awake craniotomy allows continuous monitoring of patients’ neurological functions during open surgery. Anesthesiologists have to sedate patients in a way so that they are compliant throughout the whole surgical procedure, nevertheless maintaining adequate analgesia and anxiolysis. Currently, the use of α2-receptor agonist dexmedetomidine as the primary hypnotic–sedative medication is increasing.Methods: Nine patients undergoing awake craniotomy were treated with refined monitored anesthesia care (MAC) protocol consisting of a combination of local anesthesia without scalp block, low-dose infusion of dexmedetomidine, propofol, and remifentanil, without the need of airways management.Results: The anesthetic protocol applied in our study has the advantage of decreasing the dose of each drug and thus reducing the occurrence of side effects. All patients had smooth and rapid awakenings. The brain remained relaxed during the entire procedure.Conclusion: In our experience, this protocol is safe and effective during awake brain surgery. Nevertheless, prospective randomized trials are necessary to confirm the optimal anesthetic technique to be used. Keywords: dexmedetomidine, awake surgery, anesthesia |
topic |
Dexmedetomidine Awake surgery Anesthesia |
url |
https://www.dovepress.com/awake-craniotomy-anesthetic-management-using-dexmedetomidine-propofol--peer-reviewed-article-DDDT |
work_keys_str_mv |
AT pronteraa awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT baronis awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT marudia awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT valzaniaf awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT felettia awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT benuzzif awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT bertellinie awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil AT pavesig awakecraniotomyanestheticmanagementusingdexmedetomidinepropofolandremifentanil |
_version_ |
1725562012413460480 |